VU-0486321

VU-0486321 Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: NanJing Xienuo bio Co.,Ltd.  
Tel: 025-84112752 13805181430
Email: 154301870@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354;
Email: support@targetmol.com

VU-0486321 manufacturers

  • VU0486321
  • VU0486321 pictures
  • $1980.00
  • 2026-07-15
  • CAS:1816301-67-3
  • Purity:
  • Supply Ability: 10g
VU-0486321 Basic information
Product Name:VU-0486321
Synonyms:VU-0486321;2-Furancarboxamide, N-[3-chloro-4-(4-fluoro-1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-3-methyl-
CAS:1816301-67-3
MF:C20H12ClFN2O4
MW:398.77
EINECS:
Product Categories:
Mol File:1816301-67-3.mol
VU-0486321 Structure
VU-0486321 Chemical Properties
density 1.528±0.06 g/cm3(Predicted)
form Solid
pka11.68±0.70(Predicted)
color White to off-white
Safety Information
MSDS Information
VU-0486321 Usage And Synthesis
DescriptionVU0486321 is a potent mGlu1 PAM with moderate rat PK (CLp = 13.3. mL/mikg,t1/2 = 54 min), good free fraction (human fu = 0.05, rat fu =0.03) and excellent CNS penetration (Kp = 1.02).
UsesVU0486321 is a compound in a class of mGlu1 positive allosteric modulators (PAMs). VU0486321 maintains acceptable mGlu1 PAM potency, DMPK profile, CNS permeability, and mGluR selectivity.
References[1] Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs
VU-0486321 Preparation Products And Raw materials
Tag:VU-0486321(1816301-67-3) Related Product Information
VU 0463841 [Hexahydro-5-(4-pyridinyl)pyrrolo[3,4-c]pyrrol-2(1H)-yl][1-(5-isoquinolinylsulfonyl)-3-azetidinyl]-Methanone N-(5-chloro-2-methoxyphenyl)-2-[4-(4-methylpiperidin-1-yl)sulfonylpiperazin-1-yl]acetamide VU0453595 VU 0364439 5-[1-(2-ethoxyphenyl)sulfonylazetidin-3-yl]-3-thiophen-3-yl-1,2,4-oxadiazole VU 0360223 2(5H)-Furanone, 3-(3-fluorophenyl)-4-(4-methoxyphenyl)- VU 0360172 cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide (1R,2R)-N-([S]-1-{4-[5-broMo-2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxaMide Urea, N-(3,4-difluorophenyl)-N'-[3-methyl-1-(phenylmethyl)-1H-pyrazol-5-yl]- VU0238441 VU0483605 VU0453379 VU0810464 VU-0410150